191 related articles for article (PubMed ID: 32726839)
1. Nonantibiotic Pharmacological Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations.
Vasques F; Camporota L; Barrett NA
Semin Respir Crit Care Med; 2020 Dec; 41(6):842-850. PubMed ID: 32726839
[TBL] [Abstract][Full Text] [Related]
2. Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients.
Dixit D; Bridgeman MB; Andrews LB; Narayanan N; Radbel J; Parikh A; Sunderram J
Pharmacotherapy; 2015 Jun; 35(6):631-48. PubMed ID: 26032691
[TBL] [Abstract][Full Text] [Related]
3. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
[TBL] [Abstract][Full Text] [Related]
4. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.
Wilt TJ; Niewoehner D; MacDonald R; Kane RL
Ann Intern Med; 2007 Nov; 147(9):639-53. PubMed ID: 17975187
[TBL] [Abstract][Full Text] [Related]
5. Bringing Stability to the Chronic Obstructive Pulmonary Disease Patient: Clinical and Pharmacological Considerations for Frequent Exacerbators.
Gulati S; Wells JM
Drugs; 2017 Apr; 77(6):651-670. PubMed ID: 28255962
[TBL] [Abstract][Full Text] [Related]
6. [Long-term treatment strategy in chronic obstructive pulmonary disease: how to change the course of the disease].
Devillier P; Salvator H; Roche N; Grassin-Delyle S; Naline E; Dorocant S; Neveu H
Presse Med; 2014 Dec; 43(12 Pt 1):1368-80. PubMed ID: 25455634
[TBL] [Abstract][Full Text] [Related]
7. Common lung conditions: chronic obstructive pulmonary disease.
Delzell JE
FP Essent; 2013 Jun; 409():23-31. PubMed ID: 23767419
[TBL] [Abstract][Full Text] [Related]
8. Contemporary management of chronic obstructive pulmonary disease: scientific review.
Sin DD; McAlister FA; Man SF; Anthonisen NR
JAMA; 2003 Nov; 290(17):2301-12. PubMed ID: 14600189
[TBL] [Abstract][Full Text] [Related]
9. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
[TBL] [Abstract][Full Text] [Related]
10. [Management of acute exacerbations of COPD].
Rabbat A; Guetta A; Lorut C; Lefebvre A; Roche N; Huchon G
Rev Mal Respir; 2010 Oct; 27(8):939-53. PubMed ID: 20965408
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacologic treatments of COPD depending on disease severity].
Yamaya M
Nihon Rinsho; 2011 Oct; 69(10):1821-5. PubMed ID: 22073580
[TBL] [Abstract][Full Text] [Related]
12. Bronchodilator combination therapy for the treatment of chronic obstructive pulmonary disease.
Sethi S; Cote C
Curr Clin Pharmacol; 2011 Feb; 6(1):48-61. PubMed ID: 21235463
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review.
Miravitlles M; D'Urzo A; Singh D; Koblizek V
Respir Res; 2016 Sep; 17(1):112. PubMed ID: 27613392
[TBL] [Abstract][Full Text] [Related]
14. [Medical treatment of COPD].
Vestbo J; Titlestad IL
Ugeskr Laeger; 2013 Apr; 175(18):1261-4. PubMed ID: 23651802
[TBL] [Abstract][Full Text] [Related]
15. Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β
Skolnik NS; Nguyen TS; Shrestha A; Ray R; Corbridge TC; Brunton SA
Postgrad Med; 2020 Mar; 132(2):198-205. PubMed ID: 31900019
[TBL] [Abstract][Full Text] [Related]
16. An integrated approach to the medical treatment of chronic obstructive pulmonary disease.
Rosenberg SR; Kalhan R
Med Clin North Am; 2012 Jul; 96(4):811-26. PubMed ID: 22793946
[TBL] [Abstract][Full Text] [Related]
17. Compare the efficacy and safety of long-acting anticholinergic and a combination of inhaled steroids and long-acting beta-2 agonist in moderate chronic obstructive pulmonary disease.
Saraç P; Sayıner A
Tuberk Toraks; 2016 Jun; 64(2):112-8. PubMed ID: 27481077
[TBL] [Abstract][Full Text] [Related]
18. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Spencer S; Evans DJ; Karner C; Cates CJ
Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ;
Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.
Pelaia G; Muzzio CC; Vatrella A; Maselli R; Magnoni MS; Rizzi A
Expert Opin Pharmacother; 2015; 16(13):2009-21. PubMed ID: 26194120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
